Skip to main content

Table 1 Patient demographics of 623 adult patients with chronic kidney disease attending for routine outpatient haemodiafiltration treatment. Patient demographics, dialysis prescription, co-morbidity and muscle strength. Results displayed as integers, percentage, mean ± standard deviation or median and interquartile range

From: Patient-reported intra-dialytic symptoms and post-dialysis recovery times are influenced by psychological distress rather than dialysis prescription

Variable Results
Male gender 379 (60.8)
Age, years 64.5 ± 16.2
Diabetic 287 (46.1)
Ethnicity, White 269 (43.2)
Ethnicity, Black 202 (32.4)
Ethnicity, Asian 149 (23.9)
Age, years 64.5 ± 16.2
Venous catheter, access 147 (23.6)
Arterio-venous fistula/graft access 445 (71.4)/31 (5.0)
Pre-dialysis weight, kg 71.5 (61.8–83.9)
Post-dialysis weight, kg 70.0 (60.7–82.1)
Ultrafiltration rate, mL/kg.h 6.0 (3.9–8.0)
Convection volume, L 19.1 (16.0–23.0)
Urea reduction ratio, % 74.6 (69.3–78.9)
Dialysis session time, h 4.0 (3.5–4.0)
Dialysate sodium, mmol/L 136 (136–138)
Dialysate potassium, mmol/L 2.0 (1.0–2.0)
Dialysate calcium, mmol/L 1.0 (1.0–1.25)
Dialysate temperature, °C 35.5 ± 0.7
Dialyzer surface area, m2 2.10 (1.8–2.2)
Tinzaparin, IU 2500 (2500–2500)
Serum sodium, mmol/L 139 ± 3.6
Serum urea, mmol/L 18.2 ± 5.8
Serum creatinine, umol/L 690 (547–861)
C-reactive protein, mg/L 6.0 (2.0–11.0)
Serum albumin, g/L 39 (36–41)
Haemoglobin, g/L 108.0 ± 14.3
Serum pro-brain natriuretic peptide, ng/L 5635 (1566–11,953)
Glycated haemoglobin, mmol/mol 47.5 (37.7–61.7)
Blood sugar, mmol/L 6.5 (5.4–8.2)
Prescribed antihypertensives 375 (60.2)
Myocardial infarction 115 (18.5)
Coronary artery bypass, surgery/stenting 43 (6.9)/58 (9.3)
Peripheral vascular disease 90 (16.4)
Renal artery stenosis/aortic aneurysm 24 (3.9)
Transient ischaemic attack 19 (3.1)
Cerebrovascular accident 65 (10.4)
Cancer 104 (16.7)
Frailty 4 (3–5)
Distress thermometer 3 (0–6)
Hand grip strength, kg 20.4 ± 10.5